|
|
Safety and immunological curative effect observation of measles,mumps,and rubella combined attenuated live vaccination in children |
YU Dan WANG Jing |
Center for Disease Control and Prevention of Yingtan City in Jiangxi Province,Yingtan 335001,China |
|
|
Abstract ObjectiveTo observe the clinical safety and immunological curative effect of measles,mumps,and rubella combined attenuated live vaccination in children.MethodsA total of 400 children who were vaccinated against measles,mumps and rubella live vaccines were randomly selected from January 2001 to December 2016 in the Center for Disease Control and Prevention of Yingtan City in Jiangxi Province.According to the vaccination grouping,100 cases of children vaccinated against live attenuated measles,100 cases of children with mumps attenuated live vaccination,100 patients were given rubella live attenuated vaccination,100 cases of children were given measles,mumps,and rubella combined attenuated live vaccination.The incidence of adverse events such as rash,fever,nausea and vomiting,anorexia and diarrhea were observed within 30 min after inoculation.Immunological evaluation was carried out by using antibody titer,and the geometric mean titer of each group was compared.ResultsThe incidence of adverse reactions after inoculation was 9.00% (9/100),compared with other groups,the difference was not statistically significant(P>0.05).The average geometric titers of rubella after immunization in children with measles,mumps,and rubella combined attenuated live vaccination were 1∶31,and compared with the average geometric titers of rubella vaccine group(1∶29),there was significant difference (P<0.05).There was no significant difference in the average geometric titers between measles and mumps(P>0.05).ConclusionThe preventive effect of measles,mumps,and rubella combined attenuated live vaccination is definite,compared with single measles vaccine,mumps vaccine and rubella vaccine,there is no increase in the incidence of adverse reactions,and clinical treatment is safe and reliable,but from the point of view of immunological efficacy,measles,mumps,and rubella combined attenuated live vaccination will lead to rubella geometric mean titer rise,and must pay attention to clinical staff.
|
|
|
|
|
[1] |
武晶晶,肖瑾,宋晓雁.接种麻腮风联合减毒活疫苗偶合癫痫 1 例报告[J].中国疫苗和免疫,2017,23(1):117-118.
|
[2] |
焦永卓,邓琳,安婧,等.接种麻腮风联合减毒活疫苗对甘肃省流行性腮腺炎流行特征的影响分析[J].中国疫苗和免疫,2015,21(5):529-532.
|
[3] |
Lee YJ,Jang YH,Kim P,et al.Enhancement of the safety of live influenza vaccine by attenuating mutations from coldadapted hemagglutinin[J].Virology,2016,491(6):1-9.
|
[6] |
吴志英,高慧娟,胡建锦,等.国产麻腮风减毒活疫苗免疫效果及安全性观察[J].浙江预防医学,2007,19(5):14-15.
|
[7] |
赵小冬,刘晓雪.接种麻腮风联合减毒活疫苗后发生Todd瘫痪 1 例[J].中国疫苗和免疫,2016,22(1):109-110.
|
[8] |
张辉,刘继锋,龚建仁.陕西省西安市2006~2015年麻疹、流行性腮腺炎和风疹暴发疫情及处置效果分析[J].中国疫苗和免疫,2016,22(3):289-292.
|
[11] |
张敬武.荧光定量RT-PCR滴度检测法在腮腺炎减毒活疫苗制造中的应用[J].中国药房,2015,26(18):2578-2580.
|
[4] |
Jain A,Marshall J,Buikema A,et al.Correction of description of MMR vaccine receipt coding and minor errors in MMR vaccine and autism study[J].JAMA,2016,315(2):202-204.
|
[5] |
Yang J,Martcheva M,Chen Y.Imitation dynamics of vaccine decision-making behaviours based on the game theory[J].J Biol Dyn,2016,10(1):31-58.
|
[9] |
Brotherton JM,Gertig DM,May C,et al.HPV vaccine impact in Australian women:ready for an HPV-based screening program[J].Med J Aust,2016,204(5):184.
|
[10] |
Opel DJ,Kronman MP,Diekema DS,et al.Childhood vaccine exemption policy:the case for a less restrictive alternative[J].Pediatrics,2016,137(4):e20154230.
|
[12] |
李萍萍,李伟,刘胜,等.麻疹-流行性乙型脑炎联合减毒活疫苗的安全性评价[J].中国疫苗和免疫,2015,21(1):62-67.
|
[13] |
王培生,张静蕾,王君.接种麻腮风联合减毒活疫苗引起一例病毒性脑炎的调查分析[J].医学动物防制,2013,29(12):1377-1378.
|
[14] |
Steffensen MA,Pedersen LH,Jahn ML,et al.Vaccine targeting of subdominant CD8+T cell epitopes increases the breadth of the T cell response upon viral challenge,but may impair immediate virus control[J].J Immunol,2016,196(6):2666-2676.
|
[15] |
孙晓冬,马相虎,李智,等.水痘减毒活疫苗与麻疹流行性腮腺炎风疹联合疫苗同时接种的免疫效果和安全性观察[J].中华微生物学和免疫学杂志,2016,36(3):182-188.
|
[16] |
彭时辉,文海蓉.江西省南昌市2012~2015年麻疹风疹联合减毒活疫苗疑似预防接种异常反应监测分析[J].中国疫苗和免疫,2016,22(6):679-683.
|
|
|
|